As we can learn from the bees, a healthy social organism is characterized by close interaction of all members. Similarly, Health Care Providers, the Industry, Regulators, and Payers largely depend on each other. They all share the common goal of increasing benefit for patients.
However, developing meaningful innovations, generating tangible evidence, and finding the right price is often a highly challenging and controversial procedure.
r-connect aims to facilitate interaction between the various contributors to health care. We want to support our clients with the translation of their science into tangible value and finally into price.
Hot Topics
However, developing meaningful innovations, generating tangible evidence, and finding the right price is often a highly challenging and controversial procedure.
r-connect aims to facilitate interaction between the various contributors to health care. We want to support our clients with the translation of their science into tangible value and finally into price.
See September's volume of Interdisciplinary Platform on Benefit Assessment for further information on this topic.
Want to read more? Previous volumes are available here.
Want to read more? Previous volumes are available here.
Hot Topics
- Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment(EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?, Health Policy, June 2020
- What are the (additional) benefits of registry data?, Interdisciplinary Platform on Benefit Assessment, April 2020
- Kontextuelle Evidenz - Wege zur gezielten Therapie, Schriftenreihe Interdisziplinäre Platform zur Nutzenbewertung, October 2019
 | Contact us for more information: info@r-connect.org |
